Latest filing published 07 Aug 2024 for Sage Therapeutics, Inc., €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kimi Iguchi: trading record in brief
All filings by Kimi Iguchi on record concern Sage Therapeutics, Inc., in the capacity of finance chief. In total, 67 filings cover trades dated from 23 July 2014 to 5 August 2024.
On the open market, the record shows 2 purchases worth €88k and 31 sales worth €10.2M. Sales outweigh purchases by €10.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 13 share grants and 21 option exercises.
The newest entry dates from 7 August 2024: a share grant of €30k, in Sage Therapeutics, Inc. The most recent open-market purchase was published on 7 January 2016, 3,958 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kimi Iguchi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,636 shares@ US$8.960.3% of flowCommon StockSEC:0001562180-24-006088:1
- 13,500 shares0Common StockSEC:0001562180-24-006088:0
- 11,250 shares0Common StockSEC:0001562180-24-001333:0
- 1,642 shares@ US$1.368.8% of flowCommon StockSEC:0001562180-24-000222:0
- 943 shares@ US$19.270.2% of flowCommon StockSEC:0001562180-23-007979:1
- 3,500 shares0Common StockSEC:0001562180-23-007979:0
- 3,000 shares@ US$1.3616.6% of flowCommon StockSEC:0001562180-23-002907:0
- 250 shares@ US$1.360.0% of flowCommon StockSEC:0001562180-23-001787:1
- 750 shares@ US$1.364.2% of flowCommon StockSEC:0001562180-23-001787:0
- 914 shares@ US$44.160.4% of flowCommon StockSEC:0001562180-23-001081:1
- 2,850 shares0Common StockSEC:0001562180-23-001081:0
- 1,600 shares@ US$1.368.9% of flowCommon StockSEC:0001562180-23-000354:0
- 1,800 shares@ US$1.3610.1% of flowCommon StockSEC:0001562180-23-000237:0
- 4,500 shares@ US$1.3623.5% of flowCommon StockSEC:0001562180-22-001627:0
- 1,000 shares@ US$1.360.0% of flowCommon StockSEC:0001562180-21-007224:1
- 2,500 shares@ US$1.3613.2% of flowCommon StockSEC:0001562180-21-007224:0
- 1,024 shares@ US$40.290.4% of flowCommon StockSEC:0001562180-21-006600:1
- 3,800 shares0Common StockSEC:0001562180-21-006600:0
- 822 shares@ US$58.800.4% of flowCommon StockSEC:0001562180-21-004337:2
- 2,000 shares@ US$1.360.0% of flowCommon StockSEC:0001562180-21-004337:3
- 3,500 shares0Common StockSEC:0001562180-21-004337:1
- 3,000 shares@ US$1.3614.7% of flowCommon StockSEC:0001562180-21-004337:0
- 1,500 shares@ US$1.360.0% of flowCommon StockSEC:0001562180-21-002813:0
- 1,750 shares@ US$1.360.0% of flowCommon StockSEC:0001562180-21-000189:0
- 4,000 shares@ US$1.368.0% of flowCommon StockSEC:0001562180-20-003263:0
25 of 66 declarations
